REFERENCES
- Walton K A, Buono L M. Horner syndrome. Curr Opin Ophthalmol 2003; 14: 357–363, [INFOTRIEVE], [CSA]
- Wilhelm H, Ochsner H, Kopycziok E, et al. Horner's syndrome: a retrospective analysis of 90 cases and recommendations for clinical handling. Ger J Ophthalmol. 1992; 1: 96–102, [INFOTRIEVE], [CSA]
- Weinstein J M, Zweifel T J, Thompson H S. Congenital Horner syndrome. Arch Ophthalmol. 1980; 98: 1074–1078, [INFOTRIEVE], [CSA]
- Makley T A, Abbott K. Neurogenic heterochromia. Report of an interesting case. Am J Ophthalmol. 1955; 59: 927–928, [CSA]
- Miller N R. Walsh and Hoyt's Clinical Neuro-Ophthalmology, 4th ed. Williams & Wilkins, Baltimore 1985; Vol. 2: 500–511
- Zhan G L, Toris C B, Camras C B, et al. Prostaglandin induced iris color darkening. An experimental model. Arch Ophthalmol. 1998; 116: 1065–1068, [INFOTRIEVE], [CSA]
- Stjernschantz J W, Albert D M, Hu D N, et al. Mechanism and clinical significance of prostaglandin induced iris pigmentation. Surv Ophthalmol. 2002; 47: S162–S175, (suppl. 1)[INFOTRIEVE], [CSA], [CROSSREF]
- Zamir E, Chowers I, Banin E, et al. Neurotrophic corneal endothelial failure complicating acute Horner syndrome. Ophthalmology. 1999; 106: 1692–1696, [INFOTRIEVE], [CSA], [CROSSREF]
- Diesenhouse M C, Palay D A, Newman N J, et al. Acquired heterochromia with Horner syndrome in two adults. Ophthalmology. 1992; 99: 1815–1817, [INFOTRIEVE], [CSA]